The following adult groups are at risk of vitamin D deficiency: 2
- Older people, aged 65 years and over 2
- People who have low or no exposure to the sun, for example those who cover their skin for cultural reasons, who are housebound or who are confined indoors for long periods 2
- Institutionalized or hospitalized individuals 1
- People who have darker skin, for example people of African, African-Caribbean or South Asian origin, because their bodies are not able to make as much vitamin D 2
- Obese individuals 1
- Patients being evaluated for osteoporosis 1
- Those recently treated for vitamin D deficiency and requiring maintenance therapy 1
- Use of certain concomitant medications (e.g., anticonvulsant medications, glucocorticoids) 1
- Patients with malabsorption, including inflammatory bowel disease, coeliac disease, crohn’s disease and cystic fibrosis 1
- Chronic disease that may increase risk of vitamin D deficiency: • chronic renal disease, chronic liver disease 2
- Consilient Health Altavita 25,000 IU soft capsule summary of product characteristics available on medicines.ie
- The Royal Osteoporosis Society (ROS). Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management. December 2018. V2.
IE-ALT-464(3) DoP: November 2025
Healthcare professionals are asked to report any suspected adverse reactions via: www.medicinesauthority.gov.mt/adrportal or via email: postlicensing.medicinesauthority@gov.mt or by contacting Vivian Corporation Ltd at pv@viviancorp.com or +356 22588600.
Adverse events should also be reported to Consilient Health at drugsafety@consilienthealth.com or 01 2057766.
The information on this page is intended for Healthcare Professionals who practice in Malta.